Are you Dr. Lo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 UCLA Medical Plz Ste 450
Los Angeles, CA 90095Phone+1 310-825-6911Fax+1 310-794-7005
Summary
- Dr. Roger Lo, MD is a dermatologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is affiliated with Ronald Reagan UCLA Medical Center and UCLA Medical Center-Santa Monica.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Dermatology, 2003 - 2007
- Westchester Medical CenterInternship, Internal Medicine, 2002 - 2003
- Weill Cornell MedicineClass of 2002
Certifications & Licensure
- CA State Medical License 2003 - 2025
- National Board of Physicians and Surgeons Dermatology
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Elected Member The American Society for Clinical Investigation, 2012
Publications & Presentations
PubMed
- 2 citationsThe Fanconi anemia pathway induces chromothripsis and ecDNA-driven cancer drug resistance.Justin L Engel, Xiao Zhang, Mingming Wu, Yan Wang, Jose Espejo Valle-Inclán
Cell. 2024-10-17 - 13 citationsMulti-organ landscape of therapy-resistant melanoma.Sixue Liu, Prashanthi Dharanipragada, Shirley H Lomeli, Yan Wang, Xiao Zhang
Nature Medicine. 2023-05-01 - 24 citationsBlocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma.Prashanthi Dharanipragada, Xiao Zhang, Sixue Liu, Shirley H Lomeli, Aayoung Hong
Cancer Discovery. 2023-04-03
Press Mentions
- Dr. Roger Lo Awarded NIH Grant to Tackle Melanoma Treatment ResistanceSeptember 24th, 2024
- “Rapid Autopsies” Offer New Perspective of Melanoma ProgressionMay 3rd, 2023
- Researchers Study Genetic Changes in Tumors of Recently Deceased Patients with MelanomaMay 2nd, 2023
- Join now to see all
Grant Support
- Augmenting Melanoma Response To B-RAF V600E TargetingNational Cancer Institute2010–2011
Other Languages
- Chinese (Mandarin)